معرفی
George Georgiou is a Professor and the Dula D. Cockrell Centennial Chair in Engineering #2 in the Department of Chemical Engineering at the University of Texas at Austin. His research bridges biochemical engineering and immunology, with significant translational impact including one FDA-approved therapeutic protein and four candidates in clinical trials.
His educational background includes:
- Ph.D. in Chemical Engineering, Cornell University (1987)
- M.S. in Chemical Engineering, Cornell University (1983)
- B.Sc. in Chemical Engineering, University of Manchester Institute of Science and Technology (UMIST), England (1981)
Georgiou's work focuses on three interconnected domains: (1) discovery and preclinical development of protein therapeutics for cancer and metabolic disorders; (2) molecular characterization of human antibody immunity to inform vaccine design; and (3) Fc domain engineering for next-generation antibody therapeutics. His lab pioneered technologies for profiling circulating antibodies during infection and disease, enabling novel therapeutic antibody discovery.
Analysis of recent publications (2021-2023) reveals consistent emphasis on cancer immunotherapy mechanisms, enzyme engineering for immunotherapeutics, and antibody dynamics in disease contexts. Key themes include metabolic modulation of T cell function in tumors, viral replication effects on neutralization durability, and structural flexibility in enzyme catalysis.
His exceptional contributions are recognized through election to four national academies (Engineering, Medicine, Inventors, Arts and Sciences) and numerous awards including the AIChE William H. Walker Award and being named among Nature Biotechnology's Top 20 Translational Researchers. Additional honors span society awards from ACS, AIMBE, and AAAS.
The Georgiou Lab maintains an active research program with ongoing projects in protein therapeutics and antibody engineering, supported by extensive publications in high-impact journals. Current work continues to translate biochemical principles into clinical applications through collaborations highlighted on their research website.
